P.G. 600

Manufacturer
Merck Sharp & Dohme Corp.
Effective date
2026-08-20
Label type
OTC ANIMAL DRUG LABEL
Version
11
Source
daily-update
Hydrated at
2026-09-03 03:01:03

Label at a glance#

ProductP.G. 600
Active ingredientCHORIONIC GONADOTROPIN, SERUM, HORSE
Label structure11 sections

Storage and handling

STORAGE CONDITIONS: Store at 2‑8°C (36‑46°F). Once reconstituted, P.G. 600 (serum gonadotropin and chorionic gonadotropin for injection) should be used immediately. Unused solution should be disposed of properly and not stored for future use. Spent hypodermic needles and syringes generated as a result of the use of this product must be disposed of properly in accordance with all applicable Federal, State and local...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

(serum gonadotropin and chorionic gonadotropin for injection)

Approved by FDA under NADA # 140-856

FOR ANIMAL USE ONLY

DESCRIPTION SECTION

DESCRIPTION:

Gilts normally reach puberty (begin experiencing normal estrous cycles and exhibiting regular estrus or heat) at any time between six and eight months of age, although some gilts will not have exhibited their first estrus at ten months of age. Age at first estrus is influenced by several factors including breed type, season of the year, environmental conditions, and management practice (Hurtgen, 1986).

Sows normally exhibit estrus three to seven days after weaning their litters; however, some otherwise healthy sows may not exhibit estrus for 30 days or more after weaning (Dial and Britt, 1986). The causes of delayed return to estrus in healthy sows are poorly understood, but probably include season of the year (so-called seasonal anestrus; Hurtgen, 1979), adverse environmental conditions, such as high ambient temperatures (Love, 1978), and the number of previous litters, because the condition is more prevalent after the first litter than after later litters (Hurtgen, 1986).

P.G. 600 (serum gonadotropin and chorionic gonadotropin for injection) is a combination of serum gonadotropin (Pregnant Mare Serum Gonadotropin or PMSG) and chorionic gonadotropin (Human Chorionic Gonadotropin or HCG) for use in prepuberal gilts (gilts that have not yet exhibited their first estrus) and in sows at weaning. It is supplied in freeze-dried form with sterile diluent for reconstitution.

In gilts and sows, the action of serum gonadotropin is similar to the action of Follicle-Stimulating Hormone (FSH), which is produced by the animal's anterior pituitary gland. It stimulates the follicles of the ovaries to produce mature ova (eggs), and it promotes the outward signs of estrus (heat).

The action of chorionic gonadotropin in gilts and sows is similar to the action of Luteinizing Hormone (LH), which is also produced by the animal's anterior pituitary gland. It causes the release of mature ova from the follicles of the ovaries (ovulation), and it promotes the formation of corpora lutea, which are necessary for the maintenance of pregnancy once the animals have become pregnant.

The combination of serum gonadotropin and chorionic gonadotropin in P.G. 600 induces fertile estrus in most prepuberal gilts and weaned sows three to seven days after administration (Schilling and Cerne, 1972; Britt et al., 1986; Bates et al., 1991). The animals may then be mated, or in the case of gilts, mating may be delayed until the second estrus after treatment.

NOTE: P.G. 600 IS INTENDED AS A MANAGEMENT TOOL TO IMPROVE REPRODUCTIVE EFFICIENCY IN SWINE PRODUCTION OPERATIONS. TO OBTAIN MAXIMUM BENEFIT FROM THIS PRODUCT, ESTRUS DETECTION AND OTHER ASPECTS OF REPRODUCTIVE MANAGEMENT MUST BE ADEQUATE. IF YOU ARE IN DOUBT ABOUT THE ADEQUACY OF YOUR BREEDING PROGRAM, CONSULT YOUR VETERINARIAN.

HOW SUPPLIED SECTION

HOW SUPPLIED:

One vial containing white freeze‑dried powder, and one vial containing sterile diluent. When reconstituted, the five‑dose vial (25 mL) of P.G. 600 contains:

  • SERUM GONADOTROPIN (PMSG) 2,000 INTERNATIONAL UNITS
  • CHORIONIC GONADOTROPIN (HCG) 1,000 INTERNATIONAL UNITS
  • (equivalent to 1,000 USP Units chorionic gonadotropin)

INDICATIONS & USAGE SECTION

SPL UNCLASSIFIED SECTION

INDICATIONS FOR USE:

PREPUBERAL GILTS: P.G. 600 is indicated for induction of fertile estrus (heat) in healthy prepuberal (non-cycling) gilts over five and one-half months of age and weighing at least 85 kg (187 lb).

SPL UNCLASSIFIED SECTION

SOWS AT WEANING: P.G. 600 is indicated for induction of estrus in healthy weaned sows experiencing delayed return to estrus.

WARNINGS SECTION

CAUTIONS:

Treatment will not induce estrus in gilts that have already reached puberty (begun to cycle). Gilts that are less than five and one-half months of age or that weigh less than 85 kg (187 lb) may not be mature enough to continue normal estrus cycles or maintain a normal pregnancy to full term after treatment.

Treatment will not induce estrus in sows that are returning to estrus normally three to seven days after weaning. Delayed return to estrus is most prevalent after the first litter; the effectiveness of P.G. 600 has not been established after later litters. Delayed return to estrus often occurs during periods of adverse environmental conditions, and sows mated under such conditions may farrow smaller than normal litters.

DOSAGE & ADMINISTRATION SECTION

DOSAGE AND ADMINISTRATION:

One dose (5 mL) of reconstituted P.G. 600, containing 400 International Units serum gonadotropin (PMSG) and 200 International Units chorionic gonadotropin (HCG), should be injected subcutaneously into the gilt's or sow's neck behind the ear.

Prepuberal gilts should be injected when they are selected for addition to the breeding herd. Sows should be injected at weaning during periods of delayed return to estrus.

DOSAGE & ADMINISTRATION SECTION

SPL UNCLASSIFIED SECTION

DIRECTIONS FOR USE:

Using a sterile syringe and a sterile 0.90 × 38 mm (20 G × 1½") hypodermic needle, transfer approximately 5 mL of the sterile diluent into the vial of freeze-dried powder. Shake gently to dissolve the powder. Transfer the dissolved product back into the vial of diluent and shake gently to mix. Inject one dose (5 mL) of the reconstituted solution into the gilt's or sow's neck subcutaneously behind the ear.

STORAGE AND HANDLING SECTION

STORAGE CONDITIONS:

Store at 2‑8°C (36‑46°F).

Once reconstituted, P.G. 600 (serum gonadotropin and chorionic gonadotropin for injection) should be used immediately. Unused solution should be disposed of properly and not stored for future use.

Spent hypodermic needles and syringes generated as a result of the use of this product must be disposed of properly in accordance with all applicable Federal, State and local regulations.

REFERENCES SECTION

REFERENCES:

Bates, R.O., B.N. Day, J.H. Britt, L.K. Clark and M.A. Brauer (1991). Reproductive performance of sows treated with a combination of Pregnant Mare's Serum Gonadotropin and Human Chorionic Gonadotropin at weaning in the summer. Journal of Animal Science 69:894.

Britt, J.H., B.N. Day, S.K. Webel and M.A. Brauer (1989). Induction of fertile estrus in prepuberal gilts by treatment with a combination of Pregnant Mare's Serum Gonadotropin and Human Chorionic Gonadotropin. Journal of Animal Science 67:1148.

Dial, G.D., and J.H. Britt (1986). The clinical endocrinology of reproduction in the pig. In: D.A. Morrow (ed.). Current Therapy in Theriogenology 2. W.B. Sanders Company, Philadelphia. p. 905.

Hurtgen, J.P. (1979). Seasonal breeding patterns in female swine. PhD. Dissertation, University of Minnesota.

Hurtgen, J.P. (1986). Noninfectious infertility in swine. In: D.A. Morrow (ed.) Current Therapy in Theriogenology 2 W.B. Sanders Company, Philadelphia. p. 962.

Love, R.J. (1978). Definition of a seasonal infertility problem in pigs. Veterinary Record 103:443.

Schilling, E., and F. Cerne (1972). Induction and synchronization of oestrus in prepubertal gilts and anoestrus sows by a PMS/HCG-compound. Veterinary Record 91:471.

SPL UNCLASSIFIED SECTION

252669 R3

Distributed by Intervet Inc. (d/b/a Merck Animal Health),
Rahway, NJ 07065.
Copyright © 2026 Merck & Co., Inc.,
Rahway, NJ, USA and its affiliates.
All rights reserved.
Rev. 05/2026

MERCK
Animal Health

PRINCIPAL DISPLAY PANEL - 25 mL Multi-Dose Vial Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

MERCK
Animal Health

P.G. 600®
(serum gonadotropin and chorionic gonadotropin for injection)

FOR INDUCTION OF ESTRUS IN PREPUBERAL
GILTS AND WEANED SOWS EXPERIENCING
DELAYED RETURN TO ESTRUS

5 doses with 25 mL
(0.88 fl. oz.) diluent

MERCK
Animal Health

PRINCIPAL DISPLAY PANEL - 25 mL Multi-Dose Vial Carton
PRINCIPAL DISPLAY PANEL - 25 mL Multi-Dose Vial Carton

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Choriogonadotropin AlfaACTIVE INGREDIENT6413W06WR33
Gonadotrophin, ChorionicACTIVE INGREDIENT20ED16GHEB3
Choriogonadotropin AlfaACTIVE MOIETY6413W06WR33
Gonadotrophin, ChorionicACTIVE MOIETY20ED16GHEB3
MannitolINACTIVE INGREDIENT3OWL53L36A3
Sodium Phosphate, Dibasic, AnhydrousINACTIVE INGREDIENT22ADO53M6F3
Sodium Phosphate, MonobasicINACTIVE INGREDIENT3980JIH2SW3
WaterINACTIVE INGREDIENT059QF0KO0R3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
57926-72057926-720-64

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
CHORIONIC GONADOTROPIN20ED16GHEBACTIB
SERUM, HORSEQHD0E51VONACTIB
WATER059QF0KO0RIACT

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
102024-11-26full-release2026-06-01 02:43:56

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 3 · 122 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
Sodium Phosphate, MonobasicSODIUM PHOSPHATE, MONOBASIC3980JIH2SWSYSTEM / IONTOPHORESIS14.2 mgExact identifier — unii candidate
9 equally ranked IID candidates
MannitolMANNITOL3OWL53L36AINJECTION, SUSPENSION / INTRAMUSCULAR71 mgExact identifier — unii candidate
65 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FTABLET, FOR SUSPENSION / ORAL60 mgExact identifier — unii candidate
48 equally ranked IID candidates
MannitolMANNITOL3OWL53L36APOWDER, FOR SUSPENSION / ORAL7093 mgExact identifier — unii candidate
65 equally ranked IID candidates
MannitolMANNITOL3OWL53L36APOWDER / RESPIRATORY (INHALATION)6 mgExact identifier — unii candidate
65 equally ranked IID candidates
Sodium Phosphate, MonobasicSODIUM PHOSPHATE, MONOBASIC3980JIH2SWINJECTION / INTRAMUSCULAR161 mgExact identifier — unii candidate
9 equally ranked IID candidates
MannitolMANNITOL3OWL53L36ACAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
65 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FSPRAY, METERED / NASAL7 mgExact identifier — unii candidate
48 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR139.2 mgExact identifier — unii candidate
48 equally ranked IID candidates
MannitolMANNITOL3OWL53L36ASPRAY / NASAL41.5 mgExact identifier — unii candidate
65 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FFILM / BUCCAL0.35 mgExact identifier — unii candidate
48 equally ranked IID candidates
MannitolMANNITOL3OWL53L36AGUM, CHEWING / BUCCAL891 mgExact identifier — unii candidate
65 equally ranked IID candidates
MannitolMANNITOL3OWL53L36AINJECTION / INTRAMUSCULAR106.6 mgExact identifier — unii candidate
65 equally ranked IID candidates
MannitolMANNITOL3OWL53L36ATABLET, FOR SUSPENSION / ORAL7621 mgExact identifier — unii candidate
65 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FTROCHE / ORAL28 mgExact identifier — unii candidate
48 equally ranked IID candidates
MannitolMANNITOL3OWL53L36ACAPSULE / ORAL1562 mgExact identifier — unii candidate
65 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FINJECTION, SUSPENSION / INTRALESIONAL3 mgExact identifier — unii candidate
48 equally ranked IID candidates
MannitolMANNITOL3OWL53L36ATABLET / SUBLINGUAL495 mgExact identifier — unii candidate
65 equally ranked IID candidates
Sodium Phosphate, MonobasicSODIUM PHOSPHATE, MONOBASIC3980JIH2SWINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS0.22 mgExact identifier — unii candidate
9 equally ranked IID candidates
MannitolMANNITOL3OWL53L36AGRANULE / ORAL1328 mgExact identifier — unii candidate
65 equally ranked IID candidates
MannitolMANNITOL3OWL53L36ATABLET / ORAL3391 mgExact identifier — unii candidate
65 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FSOLUTION/ DROPS / TOPICAL0.14 %w/vExact identifier — unii candidate
48 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FINJECTION, SOLUTION / SUBCUTANEOUS0.11 %w/vExact identifier — unii candidate
48 equally ranked IID candidates
MannitolMANNITOL3OWL53L36ACAPSULE, DELAYED RELEASE / ORAL2043 mgExact identifier — unii candidate
65 equally ranked IID candidates
MannitolMANNITOL3OWL53L36ATABLET, CHEWABLE / ORAL3726 mgExact identifier — unii candidate
65 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FINJECTION, SUSPENSION / INTRAMUSCULAR36 mgExact identifier — unii candidate
48 equally ranked IID candidates
MannitolMANNITOL3OWL53L36ATABLET, ORALLY DISINTEGRATING / SUBLINGUAL10.25 mgExact identifier — unii candidate
65 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FINJECTION / INTRALESIONAL28 mgExact identifier — unii candidate
48 equally ranked IID candidates
Sodium Phosphate, MonobasicSODIUM PHOSPHATE, MONOBASIC3980JIH2SWINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS13.2 mgExact identifier — unii candidate
9 equally ranked IID candidates
MannitolMANNITOL3OWL53L36ASUSPENSION, EXTENDED RELEASE / ORAL2464.6 mgExact identifier — unii candidate
65 equally ranked IID candidates
MannitolMANNITOL3OWL53L36AINJECTION, POWDER, FOR SOLUTION / PARENTERAL200 mgExact identifier — unii candidate
65 equally ranked IID candidates
MannitolMANNITOL3OWL53L36AINJECTION, SOLUTION / SUBMUCOSAL2.94 %w/vExact identifier — unii candidate
65 equally ranked IID candidates
MannitolMANNITOL3OWL53L36AINJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR105 mgExact identifier — unii candidate
65 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FCAPSULE, DELAYED RELEASE / ORAL43 mgExact identifier — unii candidate
48 equally ranked IID candidates
MannitolMANNITOL3OWL53L36ACAPSULE, COATED PELLETS / ORAL14 mgExact identifier — unii candidate
65 equally ranked IID candidates
MannitolMANNITOL3OWL53L36ASUSPENSION/ DROPS / TOPICAL0.3 %w/vExact identifier — unii candidate
65 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FINJECTION / INTRAVENOUS381 mgExact identifier — unii candidate
48 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FINJECTION / SUBCUTANEOUS20 mgExact identifier — unii candidate
48 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FSYRUP / ORAL70 mgExact identifier — unii candidate
48 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FSOLUTION / ORAL140 mgExact identifier — unii candidate
48 equally ranked IID candidates
MannitolMANNITOL3OWL53L36APOWDER, FOR SOLUTION / ORAL3767 mgExact identifier — unii candidate
65 equally ranked IID candidates
MannitolMANNITOL3OWL53L36AWAFER / ORAL642 mgExact identifier — unii candidate
65 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FINJECTION, SOLUTION / INTRAVENOUS2460 mgExact identifier — unii candidate
48 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FFILM / SUBLINGUAL6 mgExact identifier — unii candidate
48 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FINJECTION / INTRA-ARTICULAR28 mgExact identifier — unii candidate
48 equally ranked IID candidates
Sodium Phosphate, MonobasicSODIUM PHOSPHATE, MONOBASIC3980JIH2SWINJECTION, SUSPENSION / SUBCUTANEOUS0.07 %w/vExact identifier — unii candidate
9 equally ranked IID candidates
MannitolMANNITOL3OWL53L36ATABLET, EXTENDED RELEASE / ORAL1086 mgExact identifier — unii candidate
65 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FSPRAY / NASAL1 mgExact identifier — unii candidate
48 equally ranked IID candidates
MannitolMANNITOL3OWL53L36ATABLET, CHEWABLE, EXTENDED RELEASE / ORAL616 mgExact identifier — unii candidate
65 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FTABLET, FILM COATED / ORAL0.01 mgExact identifier — unii candidate
48 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FINJECTION, EMULSION / INTRAVENOUS0.28 %w/vExact identifier — unii candidate
48 equally ranked IID candidates
MannitolMANNITOL3OWL53L36AGRANULE, FOR SUSPENSION / ORAL6000 mgExact identifier — unii candidate
65 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FSUSPENSION / OPHTHALMICNAExact identifier — unii candidate
48 equally ranked IID candidates
MannitolMANNITOL3OWL53L36ASOLUTION / INTRAVENOUS15400 mgExact identifier — unii candidate
65 equally ranked IID candidates
MannitolMANNITOL3OWL53L36ASUSPENSION/ DROPS / OPHTHALMIC3.3 %w/vExact identifier — unii candidate
65 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FINJECTION, SUSPENSION / SOFT TISSUE3 mgExact identifier — unii candidate
48 equally ranked IID candidates
MannitolMANNITOL3OWL53L36ASOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC4.35 %w/wExact identifier — unii candidate
65 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FINSERT / INTRAOCULAR0.02 mgExact identifier — unii candidate
48 equally ranked IID candidates
MannitolMANNITOL3OWL53L36ACAPSULE, EXTENDED RELEASE / ORAL160 mgExact identifier — unii candidate
65 equally ranked IID candidates
Sodium Phosphate, Dibasic, AnhydrousSODIUM PHOSPHATE, DIBASIC, ANHYDROUS22ADO53M6FLOZENGE / TRANSMUCOSAL112 mgExact identifier — unii candidate
48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Chorionic GonadotropinCHORIONIC GONADOTROPINFresenius Kabi USA, LLCf93b2baa-03ac-4650-b35a-20b818d712d62025-04-11Warnings, Adverse reactionsName fallback
generic name: CHORIONIC GONADOTROPIN
Chorionic GonadotropinCHORIONIC GONADOTROPINNuCare Pharmaceuticals,Inc.312ee87a-c6c3-6111-e063-6394a90ad8d72025-03-25Warnings, Adverse reactionsName fallback
generic name: CHORIONIC GONADOTROPIN

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.